PCSK9 Inhibitors in Targeted Treatment of Hypercholesterolemia - April 26, 2016
Offered By: Mary Greeley Medical Center via YouTube
Course Description
Overview
Explore the latest advancements in treating hypercholesterolemia in this comprehensive Grand Rounds lecture delivered by Dr. Alan S. Brown, Director of the Division of Cardiology at Advocate Heart Institute. Delve into the role of PCSK9 inhibitors as part of a targeted treatment approach, gaining valuable insights from an expert in the field. Learn about the latest research, clinical applications, and potential benefits of this innovative class of drugs in managing high cholesterol levels. Enhance your understanding of cardiovascular medicine and stay up-to-date with cutting-edge therapeutic strategies in this hour-long presentation from the Mary Greeley Medical Center.
Syllabus
PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16
Taught by
Mary Greeley Medical Center
Related Courses
Take Your Medicine - The Impact of Drug DevelopmentThe University of Texas at Austin via edX Medicating for Mental Health: Judicious Use of Psychiatric Drugs
Colgate University via edX Introduction to Translational Research: Connecting Scientists and Medical Doctors
Taipei Medical University via FutureLearn よくわかる！iPS細胞 (ga019)
Kyoto University via gacco Drug Development
University of California, San Diego via Coursera